SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CAPLIN POINT LABORATORIES

BSE: 524742 30 Sep 2025
Healthcare
₹ 2276.5
Caplin Point Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

CAPLIN POINT LABORATORIES - Share Price & Details

Market Cap
₹15,483
High /Low
2,641 / 1,551
Stock P/E
27.4
Book Value
₹375.0
Dividend Yield
0.29
ROCE
25.8
ROE
₹21.7
Face Value
2.0
PEG Ratio
1.28
EVEBITDA
₹19.2
Debt
5.02
CMP / FCF
94.5
Debt to equity
₹0.0
NP Ann
541
High price all time
2,641
Piotroski score
₹5.0
Graham Number
792.0
No. Eq. Shares
7.6
Net CF
₹59.3
Net profit
567
Price to book value
5.43
Interest Coverage
₹956.0
Low price all time
1.05
Industry PE
33.0
Reserves
₹2,835
Free Cash Flow
₹241

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
25 Apr 2024 Asit C. Mehta Buy ₹1,357 ₹1,675 -27.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
CAPLIN POINT LABORATORIES LTD.2146.0858.91825.711.2615,48327.4
NATCO PHARMA LTD.12523.04641.011927.025.91147008.66
Rainbow Children's Medicare Li3540.33517.23347.485.091383053.7

Peer Comparison Chart


About CAPLIN POINT LABORATORIES

Caplin Point Laboratories Ltd., with Security Code 524742, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

STOCKS IN ACTION: TVS Motor, Caplin Point Laboratories, Medplus Health Services, Bharti Airtel, Vodafone Idea, Waaree Energies and others.

(27 Sep 2025)
Daily Business News Summary: Stay informed with the summary of Latest Business News from India and around the world, covering all...
Read more →

Caplin Point Laboratories Hits Day Low of Rs 2020 Amid Price Pressure

(26 Sep 2025)
Caplin Point Laboratories has faced a notable decline, with its stock dropping significantly over the past two days.
Read more →

Caplin Point Laboratories Builds Foundation for Double-digit Growth Trajectory

(20 Sep 2025)
Caplin Point Laboratories Ltd (Caplin) demonstrated exceptional performance in Q1FY25-26, delivering strong growth across key financial...
Read more →

Caplin Point Laboratories Reports Strong Financial Performance and Increased Investor Confidence

(17 Sep 2025)
Caplin Point Laboratories has recently experienced an evaluation adjustment, reflecting strong Q1 FY25-26 financial results, including net...
Read more →

Golden Crossovers: Caplin Point Lab among 4 stocks that signal further bullishness

(16 Sep 2025)
In the NSE list of stocks with a market cap of Rs 1000 crore, four stocks are witnessing Golden Crossovers, according to stockedge.com's...
Read more →

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

(16 Sep 2025)
Key Insights Caplin Point Laboratories will host its Annual General Meeting on 22nd of September CEO Sridhar Ganesan's...
Read more →